BeiGene Initiates Pivotal Trial of PARP inhibitor Pamiparib (BGB-290) in China in Patients With Ovarian Cancer Life Science
China Aims To Accelerate Past Detroit And Lead In Autonomous Driving, Says Nvidia Director Technology